Availability: Άμεσα Διαθέσιμο

Textbook of Von Willebrand Disease: Basic and Clinical Aspects, 2nd Edition

ISBN: 9781119419488
Εκδόσεις:
Μορφή

Hardcover

Εκδόσεις

Ημ. Έκδοσης

2024/05

Σελίδες

304

Έκδοση

2η έκδοση

Κύριος Συγγραφέας

, , ,

135,00€(Περιλαμβάνεται ΦΠΑ 6%)

Διαθεσιμότητα: 23-28 ημέρες

Περιγραφή

Comprehensive resource summarizing recent research on von Willebrand disease, showing clinicians how to optimize management of patients with this disorder

The newly revised and updated second edition of Textbook of von Willebrand Disease: Basic and Clinical Aspects, 2nd edition describes the important and complex role of von Willebrand factor (VWF) in hemostasis and thrombosis, covering not only the current understanding of its molecular biology, but also the association between genetic variants of VWF and different von Willebrand disease (VWD) phenotypes. The text also reviews the important area of the obstetric and gynecological manifestations of VWD, as well as how to manage patients with VWD for surgery.

Many advances in agents are included in this updated edition, as well as the wide topics such as VWF in Angiogenesis, and VWF/ADAMTS13 as risk factors of thrombosis.

Edited by a team of experts in VWD an international team of contributors, Textbook of Von Willebrand Disease covers sample topics such as:

  • VWF structure and function, biosynthesis and organization of VWF, modulation of VWF by ADAMTS13 and assessment of VWF clearance
  • Clinical, laboratory and molecular markers of different VWD types, from the mild forms of type 1 VWD and the moderate variants types 2A, 2B, 2M, 2N to the most severe type 3 VWD
  • Pediatric aspects of VWD and of women with VWD,
  • Management of GI bleeds and appropriate therapies in surgery, and plasma-derived and recombinant VWF concentrates
  • Acquired von Willebrand Syndrome, cardiovascular causes of AVWS, gastrointestinal bleeds in VWD and AVWS, and prophylaxis in von Willebrand disease

Providing complete and accessible coverage of the subject, Textbook of von Willebrand Disease: Basic and Clinical Aspects, 2nd edition is a valuable resource for hematologists in practice and in training, along with specialists in thrombosis, hemostasis, and bleeding/clotting disorders.

Περιεχόμενα

List of Contributors, vii

Foreword, xi

Preface, xiii

1 Historical perspective on von Willebrand disease, 1
Erik E. Berntorp and Margareta Blombäck

2 Biosynthesis and organization of von Willebrand factor, 7
Sandra L. Haberichter

3 Von Willebrand factor structure and function, 23
Robert R. Montgomery, Veronica H. Flood, and Sandra L. Haberichter

4 Regulation of von Willebrand factor expression, 39
Elham Ghorbanpour and David Lillicrap

5 Modulation of VWF by ADAMTS13, 49
Yaoxian Xu, Anastasis Petri, and James T.B. Crawley

6 Assessment of VWF clearance, 63
Orla Rawley, Laura L. Swystun, and Jamie M. O’Sullivan

7 Classification of VWD, 73
Jessica Garcia, Sandra L. Haberichter, and Veronica H. Flood

8 The epidemiology of von Willebrand disease, 81
Giancarlo Castaman and Francesco Rodeghiero

9 Clinical aspects of von Willebrand disease: bleeding history, 87
Paula D. James and Alberto Tosetto

10 Laboratory diagnosis of von Willebrand disease: the phenotype, 95
Emmanuel J. Favaloro and Ulrich Budde

11 Molecular diagnosis of von Willebrand disease: the genotype, 109
Pamela Christopherson, Robert R. Montgomery, and Veronica H. Flood

12 Clinical, laboratory, and molecular markers of type 1 von Willebrand disease and low von Willebrand factor, 115
David Lillicrap

13 Clinical and molecular markers of type 1C VWD, 123
Heather Clift, Veronica H. Flood, and Sandra L. Haberichter

14 Clinical and molecular markers of VWD2A, 129
Reinhard Schneppenheim and Giancarlo Castaman

15 Clinical and molecular markers of VWD2B, 137
Giancarlo Castaman and Augusto B. Federici

16 Clinical and molecular markers of type 2M VWD, 143
Maissaa Janbain, Sandra L. Haberichter, and Veronica H. Flood

17 Clinical and molecular markers of VWD2N, 149
Jenny Goudemand and Mélanie Daniel

18 Clinical, laboratory, and molecular markers of type 3 von Willebrand disease, 159
Luciano Baronciani and Augusto B. Federici

19 Pediatric aspects of von Willebrand disease, 177
Robert F. Sidonio Jr and Jorge Di Paola

20 Women with von Willebrand Disease, 185
Rezan Abdul Kadir

21 The use of desmopressin in von Willebrand disease, 201
Giancarlo Castaman and Augusto B. Federici

22 Plasma-derived and recombinant VWF concentrates, 215
Pier Mannuccio Mannucci and Massimo Franchini

23 Pathophysiology, epidemiology, and management of acquired von Willebrand syndrome, 221
Ulrich Budde and Augusto B. Federici

24 Cardiovascular causes of AVWS, 239
Antoine Rauch and Sophie Susen

25 Von Willebrand factor regulation of angiogenesis and vascular integrity: implications for gastrointestinal angiodysplasia and beyond, 247
Anna M. Randi and Giancarlo Castaman

26 Prophylaxis in von Willebrand disease, 257
Erik E. Berntorp and Augusto B. Federici

27 Risk of thrombosis and antithrombotic treatment in von Willebrand disease patients, 265
Ferdows Atiq and Frank W.G. Leebeek

28 Novel functions for VWF beyond hemostasis, 271
Ferdows Atiq and James S. O’Donnell

Index, 281